Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Systematic Characterization of Mutations Altering Protein Degradation in Human Cancers

ABSTRACT: Systematic Characterization of Mutations Altering Protein Degradation in Human Cancers

PROVIDER: PRJNA680298 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13112146_1.fastq.gz	Fastqsanger.gz
	SRR13112146_2.fastq.gz	Fastqsanger.gz
	SRR13112147_1.fastq.gz	Fastqsanger.gz
	SRR13112147_2.fastq.gz	Fastqsanger.gz
	SRR13112148_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 28

Similar Datasets

Systematic Characterization of Mutations Altering Protein Degradation in Human Cancers

Project description:The Ubiquitin-Proteasome System (UPS) is the primary route for selective protein degradation in human cells. We implicate transcription factors as important substrates. By developing a deep learning model (deepDegron) to identify mutations that result in degron loss, and experimentally validated predictions that gain-of-function truncating mutations in GATA3 result in increased protein stability. We profiled the DNA binding by ChIP-seq of GATA3 in response to point mutations of the implicated degron. We found an increase in DNA binding, with up-regulating peaks preferentially found near estrogen signaling related genes. To serve as control, we include GATA3 with a c-terminal FLAG-tag that would stabilize GATA3 regardless of mutation status. No significant enrichment was observed in the control.

2021-01-31 | GSE162003 | GEO

Systematic characterization of mutations altering protein degradation in human cancers.

Project description:The ubiquitin-proteasome system (UPS) is the primary route for selective protein degradation in human cells. The UPS is an attractive target for novel cancer therapies, but the precise UPS genes and substrates important for cancer growth are incompletely understood. Leveraging multi-omics data across more than 9,000 human tumors and 33 cancer types, we found that over 19% of all cancer driver genes affect UPS function. We implicate transcription factors as important substrates and show that c-Myc stability is modulated by CUL3. Moreover, we developed a deep learning model (deepDegron) to identify mutations that result in degron loss and experimentally validated the prediction that gain-of-function truncating mutations in GATA3 and PPM1D result in increased protein stability. Last, we identified UPS driver genes associated with prognosis and the tumor microenvironment. This study demonstrates the important role of UPS dysregulation in human cancer and underscores the potential therapeutic utility of targeting the UPS.

| S-EPMC9245451 | biostudies-literature

Differential Mutations In Matched Primary and Metastatic Colorectal Cancers

Project description:Differential Mutations In Matched Primary and Metastatic Colorectal Cancers

| PRJNA314364 | ENA

Driver mutations escalating the risk of distant metastasis in Korean breast cancers

Project description:Integrative systematic analyses of mutational and transcriptional profiles reveal driver mutations escalating the risk of distant metastasis in Korean breast cancers

| PRJEB9083 | ENA

Activating NOTCH1 mutations increase T-ALL cells’ chemosensitivity by altering PREX2-AKT pathway

Project description:Mutations on NOTCH1 gene are the most commonly found mutations in T-cell acute lymphoblastic leukemia (T-ALL) and they are reported to be favorable indicators for T-ALL patients' prognosis. However, the effects of activating NOTCH1 mutations on T-ALL's chemosensitivity have not been studied. We reported that NOTCH1 inhibition by gamma-secretase inhibitors or shRNA knockdown in MOLT-3 cells could reduce the T-ALL cells' sensitivity to chemotherapeutic drugs. However, this effect was absent in Jurkat and CUTLL1 cells. We further demonstrated that NOTCH1 inhibition could activate the PI3K-AKT pathway in a cell specific pattern similar as their effects on chemosensitivity. RNA-seq revealed that Phosphatidylinositol-3,4,5-Trisphosphate Dependent Rac Exchange Factor 2 (PREX2) is a target gene of NOTCH1 and may mediate the effects of activating NOTCH1 mutations on chemosensitivity. Consistently, we proved that overexpression of PREX2 could mimic the effects of NOTCH1 inhibition on chemosensitivity. Our study has highlighted the effects of activating NOTCH1 mutations on T-ALL's chemosensitivity by altering PREX2-AKT pathway, which may explain the favorable effects of NOTCH1 mutations on T-ALL patients' prognosis, as well as provided potential targets to sensitize T-ALL cells to chemotherapy.

2021-07-07 | GSE179425 | GEO

Activating NOTCH1 mutations increase T-ALL cells’ chemosensitivity by altering PREX2-AKT pathway

Project description:Activating NOTCH1 mutations increase T-ALL cells’ chemosensitivity by altering PREX2-AKT pathway

| PRJNA743671 | ENA

Systematic characterization of BAF mutations explains intra-complex synthetic lethalities

Project description:Aberrations in genes coding for subunits of the BAF chromatin remodeling complex are highly abundant in human cancers. Currently, it is not understood how these loss-of-function mutations contribute to cancer development and how they can be targeted therapeutically. The cancer type specific occurrence patterns of certain subunit mutations suggest subunit-specific effects on BAF complex function, possibly by the formation of aberrant residual complexes. Here, we systematically characterize the effects of individual subunit loss on complex composition, chromatin accessibility and gene expression in a panel of knock-out cell lines deficient for 22 targetable BAF subunits. We observe strong, specific and often discordant alterations dependent on the targeted subunit and show that these explain intra-complex co-dependencies, including the novel synthetic lethal interactions SMARCA4-ARID2, SMARCA4-ACTB and SMARCC1-SMARCC2. These data provide insights into the role of different BAF subcomplexes in genome-wide chromatin organization and suggest novel approaches to therapeutically target BAF mutant cancers.

2019-08-01 | PXD013102 | Pride

Systematic functional characterization of BAF mutations yields novel intra-complex synthetic lethalities

Project description:Systematic functional characterization of BAF mutations yields novel intra-complex synthetic lethalities

| PRJNA427139 | ENA

Mutations in AK9 impair male fertility by altering sperm motility in mice and cattle.

Project description:Mutations in AK9 impair male fertility by altering sperm motility in mice and cattle.

| PRJNA986439 | ENA

RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program

Project description:RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program

| PRJNA438536 | ENA